1. Home
  2. ETD vs ABCL Comparison

ETD vs ABCL Comparison

Compare ETD & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ethan Allen Interiors Inc.

ETD

Ethan Allen Interiors Inc.

HOLD

Current Price

$20.55

Market Cap

569.7M

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$5.72

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ETD
ABCL
Founded
1932
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Home Furnishings
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
569.7M
1.3B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
ETD
ABCL
Price
$20.55
$5.72
Analyst Decision
Hold
Strong Buy
Analyst Count
1
5
Target Price
$27.00
$8.40
AVG Volume (30 Days)
463.5K
8.4M
Earning Date
04-29-2026
05-11-2026
Dividend Yield
8.15%
N/A
EPS Growth
N/A
10.91
EPS
1.10
N/A
Revenue
$766,784,000.00
$75,128,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$2.73
$21.85
P/E Ratio
$18.58
N/A
Revenue Growth
N/A
160.56
52 Week Low
$18.28
$2.33
52 Week High
$31.41
$6.79

Technical Indicators

Market Signals
Indicator
ETD
ABCL
Relative Strength Index (RSI) 49.42 59.45
Support Level $18.28 $5.34
Resistance Level $22.89 $6.52
Average True Range (ATR) 0.52 0.47
MACD 0.20 0.10
Stochastic Oscillator 67.20 59.38

Price Performance

Historical Comparison
ETD
ABCL

About ETD Ethan Allen Interiors Inc.

Ethan Allen Interiors Inc through its subsidiaries, operates as an interior design company, and a manufacturer and retailer in the home furnishings marketplace. Its product offerings include fabric chairs, beds, wallpapers, desks, and dining tables among others. The company's reportable segments are; Wholesale and Retail. The Wholesale segment is principally involved in the development of the Ethan Allen brand and encompasses all aspects of design, manufacturing, sourcing, marketing, sale, and distribution of home furnishings and accents. The Retail segment which generates maximum revenue, sells home furnishings and accents to clients through company-operated design centers. Geographically, it derives key revenue from the United States and the rest from other regions.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

Share on Social Networks: